Wednesday March 1, 9:20 am Eastern Time
Positron Featured At 6th Annual EBT/PET Symposium Interest In PET Technology Accelerates in Japan
HOUSTON--(BUSINESS WIRE)--March 1, 2000--Positron Corporation (OTC BB: POSC) announced today that the Company and its positron emission tomography (PET) technology were featured recently at the 6th annual EBT/PET Symposium in Japan.
Sponsored by Imatron-Japan, the exclusive distributor of Positron's PET scanners in Japan, the meeting was held to present cutting-edge technologies in the diagnostic imaging arena.
Sachiko Kinoshita, President of Imatron-Japan, stated, "We were pleased to have Positron featured at the 6th annual EBT/PET meeting in Iwate, Japan, which was attended by more than 100 medical professionals from around the world. Dr. Yoshida, Professor of Internal Medicine at Chiba University, lectured on the importance of PET technology in radiological imaging applications and the role this technology will play in the future."
Ms. Kinoshita continued, "Imatron-Japan looks forward to further expanding the installed base of PET scanners in Japan and significantly increasing our market share through the sales of the Positron HZ series scanners."
Gary Brooks, President of Positron, said, "We were very pleased that Positron was featured at the annual EBT/PET meeting in Japan. Interest worldwide, particularly in Japan, in positron emission tomography (PET) continues to gain momentum. It was a great benefit to Positron to have the opportunity to showcase its PET technology at this forum and also establish new relationships with potential customers in Japan for its Posicam HZL PET scanners."
Positron Corporation is primarily engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emission tomography (PET) technology under the trade name POSICAM(TM) systems. POSICAM(TM) systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. POSICAM(TM) systems are in use at leading medical facilities, including the Cleveland Clinic Foundation, Yale University/Veterans Administration, Crawford Long Hospital, Hadassah Hebrew University Hospital in Jerusalem, Israel, Hermann Hospital and the University of Madrid.
Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other than statements of historical facts. Certain statements contained herein are forward-looking statements and, accordingly, involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. The Company's expectations, beliefs and projections are expressed in good faith and are believed by the Company to have a reasonable basis, including, without limitations, management's examination of historical operating trends, data contained in the Company's records and other data available from third parties, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. In addition to other factors and matters discussed elsewhere herein, the following are important factors that, in the view of the Company, could cause actual results to differ materially from those discussed in the forward-looking statements: the ability of the Company to attain widespread market acceptance of its POSICAM(TM) systems; the ability of the Company to obtain acceptable forms and amounts of financing to fund future operations; demand for the Company's services; and competitive factors. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT:
Positron Corporation
Gary Brooks or Robin Kelley, 650/742-8805 |
